English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Friday, May 7, 2021
エーザイ、「レンビマ」と「キイトルーダ」の併用療法について進行性腎細胞がんおよび進行性子宮内膜がんに係る申請が米国FDAより優先審査に指定
10:00 HKT/SGT
NECスペーステクノロジー、令和3年春の「黄綬褒章」を受章
10:00 HKT/SGT
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대
08:00 HKT/SGT
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
00:00 HKT/SGT
China Marks an Important Year of Promoting Carbon Neutrality
00:00 HKT/SGT
中國是促進碳中和的重要一年
00:00 HKT/SGT
中国是促进碳中和的重要一年
00:00 HKT/SGT
Thursday, May 6, 2021
全球公司董事会回应危机对管治的挑战 香港董事学会分享全球董事调查2020-2021结果
17:40 HKT/SGT
全球公司董事會回應危機對管治的挑戰 香港董事學會分享全球董事調查2020-2021結果
17:39 HKT/SGT
Corporate Boards Worldwide Navigating Governance Challenges, HKIoD Shares Findings of Global Director Survey 2020-2021
17:38 HKT/SGT
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
17:03 HKT/SGT
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
17:02 HKT/SGT
昭和電工、Infineon Technologiesとパワー半導体向けSiCエピタキシャルウェハーについて販売および共同開発契約を締結
16:30 HKT/SGT
Showa Denko and Infineon Technologies Conclude Supply Contract and Development Agreement
16:30 HKT/SGT
Filmmakers and National TV Stations May Submit Audio-Visual Productions with Original Music, Composers, Sound Designers May Compose for Films in FMC 2021
16:00 HKT/SGT
三菱重工と日本IBM、CO2流通を可視化するデジタルプラットフォーム「CO2NNEX」構築へ
15:50 HKT/SGT
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
13:13 HKT/SGT
NEC、複雑な意思決定を行う際の脳活動の知見を応用したAI技術を開発
13:10 HKT/SGT
Avance Clinical社、遺伝子技術を用いた臨床試験サービスを拡大 174億ドルの市場需要に対応
13:00 HKT/SGT
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
10:27 HKT/SGT
NEC、新型コロナウイルス(SARS-CoV-2)と結合する人工DNAアプタマーの開発に成功
10:00 HKT/SGT
Fajarbaru upbeat on property segment's outlook in Malaysia and Australia
09:00 HKT/SGT
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
07:58 HKT/SGT
Wednesday, May 5, 2021
HKTDC's Start-up Fiesta kick-starts today
19:00 HKT/SGT
India sees Huge Headroom for Growth Across TV and Digital
15:00 HKT/SGT
中信国际电讯CPC凭借「DataHOUSE AR 千里眼」于「2021年度新加坡商业评论 - 卓越科技奖 (SBR TEA 2021)」中荣膺「电讯业增强现实及虚拟现实项目(Augmented & Virtual Reality Award for Telecommunications)」奖项
12:30 HKT/SGT
中信國際電訊CPC憑「DataHOUSE AR 千里眼」於「2021年度新加坡商業評論 - 卓越科技獎 (SBR TEA 2021)」中榮膺「電訊業擴增實境及虛擬現實項目(Augmented & Virtual Reality Award for Telecommunications)」獎項
12:30 HKT/SGT
CITIC Telecom CPC's DataHOUSE AR Remote Hand wins Augmented & Virtual Reality Award for Telecommunications at SBR TEA 2021
12:30 HKT/SGT
FINXFLO Announces Binance as Latest Liquidity Provider
12:00 HKT/SGT
花旗:给予贝康医疗(2170.HK)「买入」评级,目标价40港元
11:00 HKT/SGT
花旗:給予貝康醫療(2170.HK)「買入」評級,目標價40港元
11:00 HKT/SGT
Trintech Announces Sponsorship of ServiceNow's Knowledge 2021 Event
00:00 HKT/SGT
Tuesday, May 4, 2021
顺丰房地产投资信托基金公布上市建议详情
21:00 HKT/SGT
順豐房地產投資信託基金公佈上市建議詳情
21:00 HKT/SGT
SF REIT Announces Details of Proposed Listing
21:00 HKT/SGT
卓悦与华为成为策略伙伴
19:00 HKT/SGT
卓悅與華為成為策略夥伴
19:00 HKT/SGT
Stakeholders from the Australian Government Highlight the Use of AI in Creating Smart and High-Performance Governance
18:41 HKT/SGT
中国动力策略性投资德国Quantron AG
17:00 HKT/SGT
中國動力策略性投資德國Quantron AG
17:00 HKT/SGT
China Dynamics Strategically Invests in Germany's Quantron AG
17:00 HKT/SGT
花旗医药首次覆盖贝康医疗(2170.HK): 买入/高风险评级,目标价40港币
16:00 HKT/SGT
花旗醫藥首次覆蓋貝康醫療(2170.HK): 買入/高風險評級,目標價40港幣
16:00 HKT/SGT
NTSB式報告書、ワシントン・カンパニーズを非難 橋の破壊
13:00 HKT/SGT
NTSB-style report finds The Washington Companies caused Bridge Destruction
13:00 HKT/SGT
 ACN Search:
 
CENTRESTAGE 2021 opened today at the Hong Kong Convention and Exhibition Centre. The three-day event (10 to 12 September) opens to public visitors for the first time.
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575